GleamWall
中文EN

OACC Oaktree Acquisition Corp. III Life Sciences

Blank Checks · Nasdaq · SEC CIK 2029769 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-37.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA2.1%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets5.2%
Debt / equity—
Current ratio0.32x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.14x
Accruals ratio2.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312025Q1*2024-12-31
Income statement
Revenue————————
Operating income-$2.38M-$261,958-$456,538-$255,496-$225,579-$269,810-$444,802-$303,711
Net income-$452,553$1.60M$1.39M$1.79M$1.97M$1.87M$1.66M$1.38M
EPS (diluted)————————
Balance sheet
Cash & equivalents$1.23M$1.18M$1.28M$1.43M$1.33M$1.39M$1.28M$1.36M
Current assets$1.25M$1.26M$1.42M$1.55M$1.48M$1.56M$1.48M$1.56M
Total assets$208.21M$206.54M$204.83M$203.11M$201.25M$199.18M$197.24M$195.25M
Current liabilities$3.85M$1.73M$1.62M$1.30M$1.23M$1.12M$1.06M$727,323
Total liabilities$10.87M$8.75M$8.64M$8.32M$8.25M$8.14M$8.08M$7.75M
Shareholders' equity-$9.62M-$7.49M-$7.23M-$6.77M-$6.76M-$6.54M-$6.52M-$6.07M
Cash flow statement
Operating cash flow-$204,067-$97,260-$158,035-$143,876-$56,518-$146,124-$75,561-$89,687
Investing cash flow$250,000——$250,000$0——-$191.99M

Free plan shows the latest 8 periods; Pro shows all 9 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.